Literature DB >> 21752872

Work disability in psoriatic arthritis: a systematic review.

William Tillett1, Corinne de-Vries, Neil J McHugh.   

Abstract

OBJECTIVE: Work disability (WD) is an important functional outcome measure in arthritis. There is a large body of information on WD in rheumatic diseases such as RA and AS; however, until now factors that influence WD in PsA have not been systematically reviewed. Our objective was to perform a systematic and critical review of the current literature on WD and its measurement in PsA.
METHODS: A systematic literature search was conducted using Medline, Embase and Cochrane databases. The search strategy was supplemented by a manual search of cited articles. All original English language publications in the form of meta-analyses, randomized controlled trials (RCTs), observational studies and publications in abstract form were included. A quality assessment was made of the articles published in full form.
RESULTS: Nineteen publications (nine in abstract form) were identified. There is intermediate quality evidence that levels of unemployment (20-50%) and WD (16-39%) are high and associated with longer disease duration, worse physical function, high joint count, low educational level, female gender, erosive disease and manual work. There is sparse low-quality evidence that WD is worse in those with PsA than psoriasis alone.
CONCLUSIONS: Disability at work in those with PsA is high; however, data on its associations are limited by the small number of reports and heterogeneity of data collected. Future work should focus on the validation of WD data collection tools for use in PsA.

Entities:  

Mesh:

Year:  2011        PMID: 21752872     DOI: 10.1093/rheumatology/ker216

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  25 in total

1.  Psoriatic Arthritis Quality of Life questionnaire: translation, cultural adaptation and validation into Portuguese language.

Authors:  Anabela Barcelos; Catarina Ambrósio; J A Pereira da Silva; Stephen McKenna; Jeanette Wilburn; Pedro Lopes Ferreira
Journal:  Rheumatol Int       Date:  2017-10-30       Impact factor: 2.631

Review 2.  Patient-Reported Outcomes in Psoriatic Arthritis.

Authors:  Ana-Maria Orbai; Alexis Ogdie
Journal:  Rheum Dis Clin North Am       Date:  2016-03-16       Impact factor: 2.670

3.  Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2017 MauiDerm Meeting.

Authors:  Jo Ann LeQuang
Journal:  J Clin Aesthet Dermatol       Date:  2017-09-01

4.  A Prospective Study to Evaluate the Impact of Golimumab Therapy on Work Productivity and Activity, and Quality of Life in Patients With Rheumatoid Arthritis, Psoriasis Arthritis and Axial Spondyloarthritis in a Real Life Setting in AUSTRIA. The GO-ACTIVE Study.

Authors:  Christian Dejaco; Thomas Mueller; Omid Zamani; Ulrike Kurtz; Stefan Egger; Johannes Resch-Passini; Anna Totzauer; Babak Yazdani-Biuki; Thomas Schwingenschloegl; Peter Peichl; Angelika Kraus; Gerhard W Naerr
Journal:  Front Med (Lausanne)       Date:  2022-06-02

5.  Efficacy of tocilizumab in a patient with refractory psoriatic arthritis.

Authors:  Luisa Costa; Francesco Caso; Luca Cantarini; Antonio Del Puente; Raffaele Scarpa; Mariangela Atteno
Journal:  Clin Rheumatol       Date:  2014-04-08       Impact factor: 2.980

Review 6.  Qualifying unmet needs and improving standards of care in psoriatic arthritis.

Authors:  Philip Helliwell; Laura Coates; Vinod Chandran; Dafna Gladman; Maarten de Wit; Oliver FitzGerald; Arthur Kavanaugh; Vibeke Strand; Philip J Mease; Wolf-Henning Boehncke; Richard G Langley; Ennio Lubrano; Mara Maccarone; Hendrik Schulze-Koops; Corinne Miceli-Richard; Ruben Queiro
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-12       Impact factor: 4.794

7.  Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016.

Authors:  Ana-Maria Orbai; Maarten de Wit; Philip J Mease; Kristina Callis Duffin; Musaab Elmamoun; William Tillett; Willemina Campbell; Oliver FitzGerald; Dafna D Gladman; Niti Goel; Laure Gossec; Pil Hoejgaard; Ying Ying Leung; Chris Lindsay; Vibeke Strand; Désirée M van der Heijde; Bev Shea; Robin Christensen; Laura Coates; Lihi Eder; Neil McHugh; Umut Kalyoncu; Ingrid Steinkoenig; Alexis Ogdie
Journal:  J Rheumatol       Date:  2017-02-01       Impact factor: 4.666

8.  Discriminant validity, responsiveness and reliability of the arthritis-specific Work Productivity Survey assessing workplace and household productivity in patients with psoriatic arthritis.

Authors:  Jane T Osterhaus; Oana Purcaru
Journal:  Arthritis Res Ther       Date:  2014-07-04       Impact factor: 5.156

9.  Improvements in productivity at paid work and within the household, and increased participation in daily activities after 24 weeks of certolizumab pegol treatment of patients with psoriatic arthritis: results of a phase 3 double-blind randomised placebo-controlled study.

Authors:  A Kavanaugh; D Gladman; D van der Heijde; O Purcaru; P Mease
Journal:  Ann Rheum Dis       Date:  2014-06-18       Impact factor: 19.103

10.  Patient-reported impact of spondyloarthritis on work disability and working life: the ATLANTIS survey.

Authors:  Roberta Ramonda; Antonio Marchesoni; Antonio Carletto; Gerolamo Bianchi; Maurizio Cutolo; Gianfranco Ferraccioli; Enrico Fusaro; Salvatore De Vita; Mauro Galeazzi; Roberto Gerli; Marco Matucci-Cerinic; Giovanni Minisola; Carlomaurizio Montecucco; Raffaele Pellerito; Fausto Salaffi; Giuseppe Paolazzi; Piercarlo Sarzi-Puttini; Raffaele Scarpa; Gianfilippo Bagnato; Giovanni Triolo; Guido Valesini; Leonardo Punzi; Ignazio Olivieri
Journal:  Arthritis Res Ther       Date:  2016-04-01       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.